Mounjaro generated $8.662B in Q1 2026 revenue for Eli Lilly, up 125% year over year from the prior-year quarter. The blowout growth from a single product signals strong demand momentum and likely reinforces forward earnings expectations for LLY.
Mounjaro generated $8.662B in Q1 2026 revenue for Eli Lilly, up 125% year over year from the prior-year quarter. The blowout growth from a single product signals strong demand momentum and likely reinforces forward earnings expectations for LLY.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
strongly positive
Sentiment Score
0.70
Ticker Sentiment
